Literature DB >> 28652417

K-ras Mutations as the Earliest Driving Force in a Subset of Colorectal Carcinomas.

Nikolaos Margetis1,2, Myrsini Kouloukoussa2, Kyriaki Pavlou2, Spyridon Vrakas3, Theodoros Mariolis-Sapsakos4.   

Abstract

K-ras oncogene is a key factor in colorectal cancer. Based on published and our data we propose that K-ras could be the oncogene responsible for the inactivation of the tumor-suppressor gene APC, currently considered as the initial step in colorectal tumorigenesis. K-ras fulfills the criteria of the oncogene-induced DNA damage model, as it can provoke well-established causes for inactivating tumor-suppressors, i.e. DNA double-strand breaks (causing allele deletion) and ROS production (responsible for point mutation). The model we propose is a variation of the currently existing model and hypothesizes that, in a subgroup of colorectal carcinomas, K-ras mutation may precede APC inactivation, representing the earliest driving force and, probably, an early biomarker of colorectal carcinogenesis. This observation is clinically useful, since it may modify the preventive colorectal cancer strategy, restricting numerically patients undergoing colonoscopies to those bearing K-ras mutation in their colorectum, either in benign polyps or the normal accompanying mucosa. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  K-ras mutation; benign polyp; biomarker; colorectal cancer; earliest mutation; normal mucosa; review

Mesh:

Substances:

Year:  2017        PMID: 28652417      PMCID: PMC5566900          DOI: 10.21873/invivo.11091

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  97 in total

Review 1.  The chromosomal instability pathway in colon cancer.

Authors:  Maria S Pino; Daniel C Chung
Journal:  Gastroenterology       Date:  2010-06       Impact factor: 22.682

Review 2.  Serrated and non-serrated precursor lesions of colorectal cancer.

Authors:  Cord Langner
Journal:  Dig Dis       Date:  2014-12-17       Impact factor: 2.404

Review 3.  Stem cells and their implications for colorectal cancer.

Authors:  Sebastian S Zeki; Trevor A Graham; Nicholas A Wright
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-02       Impact factor: 46.802

4.  Mutant KRAS promotes hyperplasia and alters differentiation in the colon epithelium but does not expand the presumptive stem cell pool.

Authors:  Ying Feng; Guido T Bommer; Jenny Zhao; Maranne Green; Evan Sands; Yali Zhai; Kelly Brown; Aaron Burberry; Kathleen R Cho; Eric R Fearon
Journal:  Gastroenterology       Date:  2011-05-18       Impact factor: 22.682

Review 5.  Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer.

Authors:  John M Carethers; Barbara H Jung
Journal:  Gastroenterology       Date:  2015-07-26       Impact factor: 22.682

Review 6.  Colorectal Cancer: Genetics is Changing Everything.

Authors:  Joshua C Obuch; Dennis J Ahnen
Journal:  Gastroenterol Clin North Am       Date:  2016-09       Impact factor: 3.806

7.  Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.

Authors:  Byoung-San Moon; Woo-Jeong Jeong; Jieun Park; Tae Il Kim; Do Sik Min; Kang-Yell Choi
Journal:  J Natl Cancer Inst       Date:  2014-02       Impact factor: 13.506

Review 8.  The colorectal adenoma-carcinoma sequence.

Authors:  A Leslie; F A Carey; N R Pratt; R J C Steele
Journal:  Br J Surg       Date:  2002-07       Impact factor: 6.939

Review 9.  Reactive oxygen species: a double-edged sword in oncogenesis.

Authors:  Jin-Shui Pan; Mei-Zhu Hong; Jian-Lin Ren
Journal:  World J Gastroenterol       Date:  2009-04-14       Impact factor: 5.742

10.  Detection of K-ras mutation in colonic effluent samples from patients without evidence of colorectal carcinoma.

Authors:  M Tobi; F C Luo; Z Ronai
Journal:  J Natl Cancer Inst       Date:  1994-07-06       Impact factor: 13.506

View more
  3 in total

1.  The Clinical Relevance of Frequent Germline Genetic Variants Detected by Targeted Sequencing in Patients With Rectal Adenocarcinoma (READ).

Authors:  Kevin Chih-Yang Huang; Shu-Fen Chiang; Tao-Wei Ke; William Tzu-Liang Chen; Tsung-Wei Chen; Kun-San Clifford Chao
Journal:  Cancer Genomics Proteomics       Date:  2020 May-Jun       Impact factor: 4.069

Review 2.  Fucoxanthin and Colorectal Cancer Prevention.

Authors:  Masaru Terasaki; Atsuhito Kubota; Hiroyuki Kojima; Hayato Maeda; Kazuo Miyashita; Chikara Kawagoe; Michihiro Mutoh; Takuji Tanaka
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

3.  Clinicopathological characteristics and mutational profile of KRAS and NRAS in Tunisian patients with sporadic colorectal cancer

Authors:  Donia Ounissi; Marwa Weslati; Rahma Boughriba; Meriam Hazgui; Saadia Bouraoui
Journal:  Turk J Med Sci       Date:  2021-02-26       Impact factor: 2.925

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.